FDA restricts cavity-fighting fluoride drug sales for children; Here’s why it may be risky
The FDA has restricted the sales of fluoride-based drugs for children under 3 due to potential risks such as fluorosis and effects on neurocognitive, thyroid, and gut health. These drugs, commonly available off the shelf, are prescribed as supplements to prevent tooth decay but the American Dental Association disputes the FDA's claims, citing increased cavities in communities.